Stock OLMA OLEMA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Olema Pharmaceuticals, Inc.

Equities

OLMA

US68062P1066

Market Closed - Nasdaq
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
9.69 USD +0.73% Intraday chart for Olema Pharmaceuticals, Inc. +6.95% -30.93%
May. 15 Olema Pharmaceuticals, Inc. Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 Esmo Breast Cancer Congress CI
May. 08 Olema Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Olema Pharmaceuticals, Inc. Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
CI
Olema Pharmaceuticals Insider Sold Shares Worth $269,656, According to a Recent SEC Filing
MT
Olema Pharmaceuticals Insider Sold Shares Worth $824,134, According to a Recent SEC Filing
MT
Olema Pharmaceuticals Insider Sold Shares Worth $196,233, According to a Recent SEC Filing
MT
Olema Pharmaceuticals Insider Sold Shares Worth $209,296, According to a Recent SEC Filing
MT
Olema Pharmaceuticals Insider Sold Shares Worth $117,740, According to a Recent SEC Filing
MT
Olema Pharmaceuticals Insider Sold Shares Worth $379,450, According to a Recent SEC Filing
MT
Olema Pharmaceuticals, Inc. Appoints Scott Garland to Its Board of Directors
CI
North American Morning Briefing : Stocks to Extend -2-
DJ
Peter Kushner, Chief Scientific Officer of Olema Pharmaceuticals, Inc. Announces Transition from CSO to Senior Research Fellow and Co-Founder, A Non-Executive Role, Effective April 1, 2022
CI
Olema Pharmaceuticals, Inc. Announces Management Changes
CI
Insider Sell: Olema Pharmaceuticals
MT
Olema Pharmaceuticals, Inc. Announces Board Changes
CI
Olema Oncology Appoints Sandra J. Horning, M.D., to Board of Directors
CI
Olema Oncology Announces Management Changes
CI
Olema Oncology Announces CEO Changes
CI
Olema Oncology Announces Appointment of Ian T. Clark and Cynthia M. Butitta to Board of Directors
CI
Olema Oncology Announces Management Appointment
CI
Olema Oncology Appoints Shane Kovacs as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OLMA Stock
  4. News Olema Pharmaceuticals, Inc.
  5. Insiders